Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data OCTAVE SPECIALTY GROUP INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
507
622
511
496
156
282
53.6
125
236
251
General and administrative
92
111
56.3
67
129
192
Interest expense
124
120
242
269
222
187
0
0
9.38
18.6
Interest income
289
337
265
183
103
78
2.16
3.7
4.9
Pre-tax income
105
-284
273
-183
-440
2
-35.7
-24.2
-59.8
-101
Income tax
30.7
44
5
32
-3
18
-0.46
0.99
0.92
5.21
Income from continuing operations
-36.1
-24.6
-59.3
-98.4
Net income to minority interests
-0.53
0
0
Net income
74.8
-329
186
-216
-437
-17
522
4.95
-556
-259
EPS, basic
1.66
-7.25
4.07
-4.69
-9.47
-0.61
11.48
0.18
-11.96
-5.93
EPS, diluted
1.64
-7.25
3.99
-4.69
-9.47
-0.61
11.48
0.18
-11.96
-5.93
Shares, basic (weighted)
45.4
45.7
45.7
46
46.1
46.5
45.7
45.6
47
47.2
Shares, diluted (weighted)
45.4
46.6
46.6
46
46.1
46.5
45.7
45.6
47
47.2
Balance sheet
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
91
624
63
24
20
17
6.33
7.34
29.6
68.4
Short-term investments
492
414
507
201
128
146
Receivables
9.42
55.4
86.5
Lease right-of-use assets
14
25
25
23
21
18.4
18.1
9.19
Goodwill
46
46
46.1
69.7
418
540
Intangible assets
847
719
427
409
362
326
61.4
345
475
Total assets
23,192
14,589
13,320
13,220
12,303
7,973
8,428
8,058
2,223
Short-term debt
150
0
Total liabilities
21,547
12,956
11,783
12,074
11,187
6,647
6,997
6,863
1,137
Total debt
992
2,929
2,822
2,739
2,230
639
508
0
118
Paid-in capital
200
219
232
242
257
274
292
331
370
Retained earnings
1,234
1,421
1,203
759
726
1,245
1,246
684
370
Treasury stock
-0.47
0
0
-1
-3
-15
-16.6
-28.3
-33.5
Other comprehensive income
-39
-52
-49
42
79
58
-253
-160
-188
8.48
Shareholders' equity
1,381
1,592
1,477
1,080
1,038
1,252
1,362
798
716
Minority interests
264
41
60
60
60
53
53
198
117
Total equity
1,978
1,645
1,633
1,536
1,140
1,098
1,305
1,415
996
833
Total liabilities and equity
23,192
14,589
13,320
13,220
12,303
7,973
8,428
8,058
2,223
Shares outstanding
45.3
45.6
45.8
46.3
45
45.2
46.5
45
Cash flow statement
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
74.3
-329
267
-216
-437
-16
-35.2
-23.2
-58.9
-95.8
Depreciation and amortization
1.22
1
1
0
1
2
0.87
5.23
19.9
42
Stock-based compensation
5.25
4
12
12
11
14
11.2
12.3
9.36
9.71
Deferred income tax
-0.02
31
5
-1
-10
6
-0.01
-1.51
-3.12
-10.3
Cash from operations
830
-221
-1,543
-311
-175
-131
1,335
200
0.76
-52.3
Acquisitions
74
0
-18.4
-6.95
-244
-218
Purchases of investments
-343
-43.5
-33.2
-60.5
-25.6
Sales and maturities of investments
1,317
814
432
379
137
698
18.1
15.1
21.6
37.7
Cash from investing
-453
1,163
1,588
1,000
432
776
866
435
-166
200
Debt issued
117
Debt repaid
-19.6
-69
-191
0
0
Share buybacks
-14.2
-4.51
-11.7
-29.9
Cash from financing
-319
-412
-585
-691
-303
-657
-2,163
-0.72
28.6
21.4
Exchange rate effect
-3.91
-1
0
0
0
0
-1
0
-0.56
1.46
Net change in cash
54.3
529
-541
-2
-46
-12
38
213
Income taxes paid
21.4
40
35
21
11
15
0.35
0
0.53
5.55
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.19 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Pre-tax margin
-24.3%
Pre-tax income / revenue.
Net margin
-49.5%
Net income / revenue.
Return on equity (ROE)
-22.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-7.0%
Net income / average total assets.
Stock-based pay / revenue
4.3%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
14.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
6.5%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
67.3%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
10.0%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y
-6,961.0%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-10.3%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-17.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-7.9%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-72.4%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-34.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-30.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
1.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
0.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Debt / equity
0.22x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
6.8%
Total debt / total assets.
Liabilities / assets
55.5%
Total liabilities / total assets.
Net debt
-$6.2M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$7.06
Revenue / diluted weighted shares.
Book value per share
$15.52
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.59x
Market cap / revenue.
P/B
0.27x
Market cap / shareholders' equity. Only when equity is positive.
EV/Sales
0.57x
Enterprise value / revenue.
Earnings yield
-84.1%
Net income / market cap (the inverse of P/E).
What was OCTAVE SPECIALTY GROUP INC's revenue in fiscal 2025?
OCTAVE SPECIALTY GROUP INC reported revenue of $251.2M for fiscal 2025, 6.5% higher than the year before.
Was OCTAVE SPECIALTY GROUP INC profitable in fiscal 2025?
No. It reported a net loss of $259.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.